EPIS B — Episurf Medical AB Income Statement
0.000.00%
Last trade - 00:00- SEK78.89m
- SEK52.89m
- SEK13.10m
Annual income statement for Episurf Medical AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 7 | 6.9 | 6.9 | 10.6 | 13.1 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 70.4 | 76.3 | 83.9 | 107 | 90.3 |
| Operating Profit | -63.4 | -69.4 | -77 | -96.7 | -77.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -63.9 | -69.2 | -77.2 | -94.6 | -76 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -63.9 | -69.2 | -77.3 | -94.9 | -76.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -63.9 | -69.2 | -77.3 | -94.9 | -76.1 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -63.9 | -69.3 | -77.3 | -94.8 | -76 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.304 | -0.236 | -0.224 | -0.274 | -0.154 |
| Dividends per Share |